Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2012
05/24/2012CA2817785A1 Pyrazolopyridines and pyrazolopyridines and their use as tyk2 inhibitors
05/24/2012CA2817784A1 Method of treating contrast-induced nephropathy
05/24/2012CA2817663A1 Imidazole derivatives as pde10a enzyme inhibitors
05/24/2012CA2817564A1 Preselection of subjects for therapeutic treatment based on hypoxic status
05/24/2012CA2817542A1 Methods for enhancing oxygenation of jeopardized tissue
05/24/2012CA2817537A1 Fgfr1 extracellular domain combination therapies
05/24/2012CA2817536A1 Method for treating breast cancer and ovarian cancer
05/24/2012CA2817521A1 Heterocyclic compounds as imaging probes of tau pathology
05/24/2012CA2817505A1 Pharmaceutical formulation having neuroprotective activity
05/24/2012CA2817388A1 Quinolinone derivatives
05/24/2012CA2817372A1 Performance enhancing sports beverage and methods of use
05/24/2012CA2817362A1 Lipoyl compounds and their use for treating ischemic injury
05/24/2012CA2817250A1 Novel compositions and uses of anti-hypertension agents for cancer therapy
05/24/2012CA2817165A1 Novel antiviral compounds
05/24/2012CA2817133A1 Methods of treating tumors
05/24/2012CA2817114A1 Substituted amino bisphenyl pentanoic acid derivatives as nep inhibitors
05/24/2012CA2817093A1 Nampt inhibitors
05/24/2012CA2816997A1 Novel polymer derivative of cytidine metabolic antagonist
05/24/2012CA2816952A1 Crystalline pharmaceutically active ingredients
05/24/2012CA2816810A1 Crystalline form of an inhibitor of mdm2/4 and p53 interaction
05/24/2012CA2816789A1 Aminoglycosides and uses thereof in treating genetic disorders
05/24/2012CA2816679A1 3-(aminoaryl)-pyridine compounds
05/24/2012CA2816660A1 Pharmaceutical composition comprising citrate and bicarbonate salts, and use thereof for treating cystinuria
05/24/2012CA2816594A1 Nampt and rock inhibitors
05/24/2012CA2816144A1 Quinoline derivatives as pik3 inhibitors
05/24/2012CA2815898A1 Transdermal therapeutic system comprising buprenorphine
05/24/2012CA2815810A1 Compositions with antibacterial and wound healing activity
05/24/2012CA2815382A1 Local vascular delivery of adenosine a2a receptor agonists to reduce myocardial injury
05/24/2012CA2815340A1 Compositions and methods for treating erectile dysfunction
05/24/2012CA2814826A1 Bridged spiro[2.4]heptane ester derivatives
05/24/2012CA2813451A1 Methods of diagnosing and treating neurodegenerative diseases
05/23/2012EP2455469A1 Nucleic acid molecule capable of binding to hmgb1, and use thereof
05/23/2012EP2455467A1 Double-stranded oligonucleotides
05/23/2012EP2455466A1 Dna fragment and pharmaceutical composition
05/23/2012EP2455456A1 Use of kinesin inhibitors in HIV infection treatment and a method for screening them
05/23/2012EP2455387A1 Oligosaccharide mixture and food product comprising this mixture, especially infant formula
05/23/2012EP2455386A1 Low molecular weight pharmacological activity modulators
05/23/2012EP2455383A2 4 -substituted azaadamantane derivatives and methods of use thereof
05/23/2012EP2455382A1 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors
05/23/2012EP2455381A1 Triazolopyridine compound, and action thereof as prolyl hydroxylase inhibitor and erythropoietin production inducer
05/23/2012EP2455380A1 Heterocyclic compound and use thereof
05/23/2012EP2455379A1 Crystals of pyrroloquinolinequinone sodium salts
05/23/2012EP2455378A1 Carbazole and carboline derivatives, and preparation and therapeutic applications thereof
05/23/2012EP2455377A1 Synthesis of fentanyl analogs
05/23/2012EP2455376A1 Heterocyclic compounds as inhibitors of hepatitis C virus (HCV)
05/23/2012EP2455375A2 Diacylhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complex
05/23/2012EP2455372A1 Process for producing crystals of polymorphic 2-(3-cyano-4-isobutyloxyphenyl)-4-methyl-5-thiazolecaboxylic acid by poor-solvent addition method
05/23/2012EP2455370A1 Pharmaceutical product containing lactam or benzene sulfonamide compound
05/23/2012EP2455369A1 Derivatives of 2-aryl-4-quinolones having an aminoalkyl group as anticancer agents
05/23/2012EP2455368A1 2-[[[2-[(hydroxyacetyl)amino]-4-pyridinyl]methyl]thio]-n-[4-(trifluoromethoxy)phenyl]-3-pyridinecarboxamide benzene- sulfonate, crystals of same, polymorphs thereof, and processes for production thereof
05/23/2012EP2455367A1 Tetracycline derivatives for the treatment of bacterial, viral and parasitic infections
05/23/2012EP2455363A1 Method for manufacturing spilanthol and intermediate manufacturing product therefor
05/23/2012EP2455362A1 Nuclear receptor binding agents
05/23/2012EP2455105A2 Bombesin analogues
05/23/2012EP2455103A1 Anti-cancer agent, method for inducing apoptosis of cancer cells, and method for screening for anti-cancer agent
05/23/2012EP2455091A1 Angiogenesis-regulating composition and angiogenesis regulation method
05/23/2012EP2455090A1 Agent for inhibiting increase in postprandial blood insulin level
05/23/2012EP2455089A1 Inhibitor of blood gip level elevation
05/23/2012EP2455088A1 Inhibitor of blood triglyceride level elevation
05/23/2012EP2455087A2 Isolation and identification of heparan sulphate
05/23/2012EP2455086A1 Use of chitosans for the treatment of nail inflammatory diseases
05/23/2012EP2455085A2 Use of at least one compound of the family of the avermectins or of the family of the milbemycins in the treatment of ophthalmic pathologies
05/23/2012EP2455084A2 Antihypertensive composition containing a ginsenoside-enriched fraction
05/23/2012EP2455083A1 Pharmaceutical composition for dermal use comprising calcipotriol and a corticosteroid
05/23/2012EP2455082A1 Insulin-producing cell inducer, glucose intake enhancer, and therapeutic agent for diabetes or diabetes complications
05/23/2012EP2455081A1 S1P1 receptor agonists for use in the treatment of crohn's disease
05/23/2012EP2455080A1 S1P1 receptor agonists for use in the treatment of multiple sclerosis
05/23/2012EP2455079A2 Composition for the prevention or treatment of bone diseases comprising colforsin daropate
05/23/2012EP2455077A1 Prophylactic and/or therapeutic agent for dysmenorrhea
05/23/2012EP2455076A1 Compositions comprising desvenlafaxine for use in treating sleep-related breathing disorders
05/23/2012EP2455075A1 Combinations of Eszopiclone and trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-napthalenamine or trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine, and Methods of Treatment of Menopause and Mood, Anxiety, & Cognitive Disorders
05/23/2012EP2455074A1 Topical pharmaceutical compositions of flurbiprofen and methyl salicylate
05/23/2012EP2455073A1 Combination of substances for the treatment of patients with hypercholesterolemia and related disorders
05/23/2012EP2455071A1 Capsule Formulation
05/23/2012EP2455070A1 Capsule Formulation
05/23/2012EP2455069A1 Non-active administration form, method for producing same and use of same
05/23/2012EP2455068A1 Pharmaceutical composition for treating HCV infections
05/23/2012EP2455066A1 Pharmacological preparation for topical use containing n-palmitoyl-vanillamide
05/23/2012EP2455064A1 Device for treating a periodontal disease
05/23/2012EP2454948A1 Oligosaccharide mixture and food product comprising this mixture, especially infant formula
05/23/2012EP2454945A1 Methods of improving mental or physical health conditions in an individual
05/23/2012EP2454589A1 Method of assaying 5-fu
05/23/2012EP2454372A2 Treatment and diagnosis of immune disorders
05/23/2012EP2454371A2 Chemical modification of small hairpin rnas for inhibition of gene expression
05/23/2012EP2454268A1 2,3-fluorinated glycosides as neuraminidase inhibitors and their use as anti-virals
05/23/2012EP2454267A2 Metal complexes having dual histone deacetylase inhibitory and dna-binding activity
05/23/2012EP2454266A1 9e-15-(2-pyrrolidin-1-yl-ethoxy)-7,12,25-trioxa-19,21,24-triaza- tetracyclo[18.3.1.1(2,5).1(14)18)]hexacosa-1(24),2,4,9,14,16,18(26),20,22-nonaene citrate salt
05/23/2012EP2454265A2 Deuterated 2, 4-pyrimidinediamine compounds and prodrugs thereof and their uses
05/23/2012EP2454264A1 Tricyclic indole-derived spiro derivatives as crth2 modulators
05/23/2012EP2454263A1 3-hydroxypyrrolidine inhibitors of 5'-methylthioadenosine phosphorylase and nucleosidase
05/23/2012EP2454259A1 Deuterium-modified triazolo-pyridazine derivatives as gaba-a receptor modulators
05/23/2012EP2454258A1 Heterocyclic compounds as autotaxin inhibitors
05/23/2012EP2454257A1 Pyrrolopyridine inhibitors of kinases
05/23/2012EP2454256A1 Process for the synthesis of paliperidone
05/23/2012EP2454255A1 Pyridin-4-yl derivatives
05/23/2012EP2454254A2 Benzimidazole analogues for the treatment or prevention of flavivirus infections
05/23/2012EP2454253A1 Aminopyridine derivatives for treating tumors and inflammatory diseases
05/23/2012EP2454252A1 Spiro amino compounds suitable for the treatment of inter alia sleep disorders and drug addiction
05/23/2012EP2454251A1 Gpr119 agonists
05/23/2012EP2454250A1 Apoptosis signal-regulating kinase inhibitors
1 ... 1215 1216 1217 1218 1219 1220 1221 1222 1223 1224 1225 1226 1227 1228 1229 1230 1231 1232 1233 1234 1235 ... 7860